Physician profile
Baseer Syed
NPI 1124524616
$1,418.40
in general payments reported to CMS, 2019-2025
23 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.45 · 2023: $403 · 2024: $482 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $399.02 | 2022-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $191.99 | 2023-2025 | Andexxa, Airsupra, Farxiga |
| Paratek Pharmaceuticals, INC. | $153.79 | 2023-2024 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $96.16 | 2024-2025 | |
| Madrigal Pharmaceuticals | $64.23 | 2025 | Rezdiffra |
| Stryker Corporation | $61.13 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $51.98 | 2024-2025 | Ozempic, Rybelsus |
| Alexion Pharmaceuticals, INC. | $49.44 | 2023 | Ultomiris |
| Ferring Pharmaceuticals INC. | $39.77 | 2022 | |
| Janssen Scientific Affairs, LLC | $35.82 | 2023 | Xarelto |
| Baxter Healthcare | $34.22 | 2023 | Hillrom - Life 2000 Ventilation System |
| Aimmune Therapeutics, INC. | $34.15 | 2025 | Vowst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.67 | 2023 | Spevigo |
| Lundbeck LLC | $23.60 | 2025 | Rexulti |
| Electromed, INC. | $19.81 | 2024 | Smartvest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.88 | 2023 | Watchman Access System |
| Vertex Pharmaceuticals Incorporated | $17.69 | 2025 | |
| Edwards Lifesciences Corporation | $17.65 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $17.62 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Gilead Sciences, INC. | $16.66 | 2023 | Veklury |
| Janssen Pharmaceuticals, INC | $14.78 | 2023 | Xarelto |
| Neurelis, INC. | $14.32 | 2024 | Valtoco |
| Alnylam Pharmaceuticals INC. | $13.02 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baseer Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.